General Information of Drug (ID: DMMNP2F)

Drug Name
G17DT Drug Info
Synonyms Gastrimmune; Insegia
Indication
Disease Entry ICD 11 Status REF
Gastric adenocarcinoma 2B72 Phase 3 [1]
Cross-matching ID
TTD Drug ID
DMMNP2F

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Gastrin (GAST) TT4LRVO GAST_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT02118077) Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer. U.S. National Institutes of Health.
2 G17DT: an antigastrin immunogen for the treatment of gastrointestinal malignancy. Expert Opin Biol Ther. 2007 Mar;7(3):397-404.